Call Us Today! +8801773428128

Gilternib 40 Mg (Gilteritinib)

Product Name: Gilternib 40 mg (Gilteritinib)
Manufacturer: Everest Pharmaceuticals
Category: Oncology/Leukemia Treatment

Category:

Product Description

Gilternib 40 mg (Gilteritinib) is an advanced oral medication specifically designed to target FLT3-mutated acute myeloid leukemia (AML). As a tyrosine kinase inhibitor, Gilternib works by blocking abnormal signals in cancer cells, thereby inhibiting growth and promoting cell death in leukemia cells. It is especially effective in cases of relapsed or refractory AML where other treatments have failed, offering renewed hope for patients.

Gilternib 40mg Gilteritinib Key Benefits:

  • Targeted Therapy: Specifically inhibits FLT3 mutations found in a subset of AML patients.
  • Proven Efficacy: Demonstrates significant clinical success in inducing remission and prolonging survival in relapsed AML cases.
  • Convenient Dosing: Available in easy-to-take 40 mg tablets, typically prescribed as a daily dose of 120 mg (three tablets).
  • Broad Application: Suitable for use in patients who are refractory to chemotherapy or have experienced a relapse.

How to Use Gilternib 40mg Gilteritinib :

  • Dosage: Take as prescribed by your healthcare provider, typically 120 mg once daily (three 40 mg tablets).
  • Can be taken with or without food. Swallow the tablets whole with a glass of water.
  • It is important to follow your doctor’s instructions regarding dosing and duration.

Side Effects:
Common side effects may include nausea, diarrhea, fatigue, and liver function abnormalities. More serious effects like QT prolongation (heart rhythm disturbances) may occur, so regular monitoring is recommended. Always consult your healthcare provider for any concerns during treatment.

Precautions:

  • Monitoring Required: Regular blood tests and heart function tests are essential to ensure safe use.
  • Not recommended for patients with certain heart conditions unless under close medical supervision.

Storage:
Store Gilternib 40 mg at room temperature (20-25°C), away from moisture and direct light.

Why Choose Gilternib 40mg?

Gilternib 40 mg is a leading option for FLT3-mutated AML treatment, providing a tailored, targeted therapy that has shown remarkable clinical results. With Everest Pharmaceuticals’ dedication to quality and innovation, this product meets the highest standards in oncology care.

Order Now to take advantage of competitive pricing and worldwide shipping from Mediaid Pharmacy.

Additional information

Brand

Everest Pharmaceuticals

Generic Name

Gilteritinib